ArticleJournal of human genetics2026
A trio-based long-read sequencing workflow identifies a pathogenic transposable element insertion in a previously undiagnosed patient.
Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
Abstract
Long-read sequencing (LRS) is a powerful tool for detecting structural variants (SVs), which are major causes of genetic diseases. However, the application of trio-based analysis to LRS data remains challenging due to the complexity of merging and comparing SVs across individuals. Here, we established a workflow to prioritize pathogenic SVs using trio-based LRS whole-genome sequencing. The workflow integrates high-accuracy basecalling, trio-based phasing, and multiple SV callers (CuteSV and Sniffles2). We employed the PanPop Realign and Thin (PART) process to merge SVs and utilized the JSV1 Japanese population-specific SV frequency dataset to filter common variants. We evaluated this workflow using 12 family trios from the Initiatives for Rare and Undiagnosed Diseases (IRUD) project. The workflow successfully prioritized candidate SVs by narrowing down tens of thousands of loci to less than ~20 with X-linked homozygous and de novo models for manual inspection. Notably, we identified a pathogenic AluY element insertion in the GPC3 gene in a patient with Simpson-Golabi-Behmel syndrome. This variant had been missed by previous short-read whole-exome sequencing but was clearly prioritized by our LRS workflow. Our workflow effectively prioritizes pathogenic SVs from LRS data, demonstrating the clinical utility of LRS for diagnosing rare diseases involving complex SVs without prior knowledge of candidate genes or loci.
Indexed as
Identifiers
42332059What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.